Preferred Stock, Shares Authorized of Kymera Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Kymera Therapeutics, Inc. quarterly Preferred Stock, Shares Authorized in shares history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Kymera Therapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending 31 Dec 2025 was 10,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Change (%)

Kymera Therapeutics, Inc. Quarterly Preferred Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 10,000,000 0 0% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 10,000,000 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 10,000,000 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q4 2024 10,000,000 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2021 10,000,000 0 0% 31 Dec 2021 10-K 24 Feb 2022 2021 FY
Q3 2021 10,000,000 0 0% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 10,000,000 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 10,000,000 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 10,000,000 +10,000,000 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 10,000,000 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q4 2019 0 31 Dec 2019 10-K 11 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.